146 related articles for article (PubMed ID: 2635)
21. Genetical control of B-cell responses. III. Requirement for functional mitogenicity of the antigen in thymus-independent specific responses.
Coutinho A; Gronowicz E
J Exp Med; 1975 Apr; 141(4):753-60. PubMed ID: 1092788
[TBL] [Abstract][Full Text] [Related]
22. Lipopolysaccharide-induced autoantibody response. II. Age-related change in plaque-forming cell response to bromelain-treated syngeneic erythrocytes.
Fujiwara M; Kariyone A
Int Arch Allergy Appl Immunol; 1981; 66(2):161-72. PubMed ID: 6456997
[TBL] [Abstract][Full Text] [Related]
23. Regulatory role of T cells in IgG antibody formation and immune memory to type III Pneumococcal polysaccharide.
Braley-Mullen H
J Immunol; 1974 Dec; 113(6):1909-20. PubMed ID: 4154347
[No Abstract] [Full Text] [Related]
24. The effect of antilymphocytic antibody on the humoral immune response of different strains of mice. V. Effects on the class and subclass of antibody produced, and the antibody responses of congenitally athymic mice.
Warr GW; James K
Clin Exp Immunol; 1974 Dec; 18(4):571-8. PubMed ID: 4157132
[TBL] [Abstract][Full Text] [Related]
25. Modulation of the immune response to lipopolysaccharide.
Hiernaux JR; Baker PJ; Delisi C; Rudbach JA
J Immunol; 1982 Mar; 128(3):1054-8. PubMed ID: 7035556
[TBL] [Abstract][Full Text] [Related]
26. The role of a functionally distinct IgM anti-type III pneumococcal polysaccharide (SIII) in low-dose paralysis to SIII in mice.
Kearney R; Andrews J; Johnstone S
Aust J Exp Biol Med Sci; 1986 Feb; 64 ( Pt 1)():19-35. PubMed ID: 2938567
[TBL] [Abstract][Full Text] [Related]
27. The effect of Bordetella pertussis on the antibody response in mice to type III pneumococcal polysaccharide.
Kong AS; Morse SI
J Immunol; 1976 Apr; 116(4):989-93. PubMed ID: 3610
[TBL] [Abstract][Full Text] [Related]
28. Two defects in old New Zealand Black mice are involved in the loss of low-dose paralysis to type III pneumococcal polysaccharide.
McCoy KL; Baker PJ; Stashak PW; Chused TM
J Immunol; 1985 Oct; 135(4):2438-42. PubMed ID: 3875654
[TBL] [Abstract][Full Text] [Related]
29. Regulation of the antibody response to type 3 pneumococcal polysaccharide. 3. Role of regulatory T cells in the development of an IgG and IgA antibody response.
Barthold DR; Prescott B; Stashak PW; Amsbaugh DF; Baker PJ
J Immunol; 1974 Mar; 112(3):1042-50. PubMed ID: 4149561
[No Abstract] [Full Text] [Related]
30. Neonatal infection with mouse thymic virus: effects on cells regulating the antibody response to type III pneumococcal polysaccharide.
Morse HC; Cross SS; Baker PJ
J Immunol; 1976 Jun; 116(6):1613-7. PubMed ID: 5561
[TBL] [Abstract][Full Text] [Related]
31. Structural and genetic basis of the in vivo immune response to TNP-LPS.
Jacobs DM
J Immunol; 1975 Oct; 115(4):988-92. PubMed ID: 1100725
[TBL] [Abstract][Full Text] [Related]
32. Generation of low-dose paralysis in the absence of the ability to secrete antibody.
Markham RB; Stashak PW; Prescott B; Amsbaugh DF; Baker PJ
J Immunol; 1978 Mar; 120(3):986-90. PubMed ID: 24665
[TBL] [Abstract][Full Text] [Related]
33. The regulation of the immune response of mice to Haemophilus influenzae type b capsular polysaccharide.
Lee CJ; Malik FG; Robbins JB
Immunology; 1978 Jan; 34(1):149-56. PubMed ID: 75178
[TBL] [Abstract][Full Text] [Related]
34. Models for assessing the effect of toxicants on immunocompetence in mice. II. Effect of cyclophosphamide on the antibody responses to type III pneumococcal polysaccharide and tetanus toxoid in BALB/c female mice.
Speirs RS; Benson RW; Knowles BJ; Roberts D
J Environ Pathol Toxicol; 1978; 1(6):791-812. PubMed ID: 32218
[TBL] [Abstract][Full Text] [Related]
35. The immunological properties of haptens coupled to thymus-independent carrier molecules. I. The characteristics of the immune response to dinitrophenyl-lysine-substituted pneumococcal polysaccharide (SIII) and levan.
Klaus GG; Humphrey JH
Eur J Immunol; 1974 May; 4(5):370-7. PubMed ID: 4153121
[No Abstract] [Full Text] [Related]
36. Studies on the immune response of congenitally athymic (nude) mice.
Jutila JW; Reed ND; Isaak DD
Birth Defects Orig Artic Ser; 1975; 11(1):522-7. PubMed ID: 238688
[TBL] [Abstract][Full Text] [Related]
37. Letter: The basis for conflicting results obtained in studies on the plaque-forming cell response to type III pneumococcal polysaccharide.
Baker PJ; Prescott B
J Immunol; 1975 Sep; 115(3):891-2. PubMed ID: 239066
[No Abstract] [Full Text] [Related]
38. Inhibition of murine plaque-forming cell responses in vivo by ribavirin.
Peavy DL; Powers CN; Knight V
J Immunol; 1981 Mar; 126(3):861-4. PubMed ID: 7007503
[TBL] [Abstract][Full Text] [Related]
39. Responses to polyvinyl pyrrolidone and pneumococcal polysaccharide in protein-deficient mice.
Price P
Immunology; 1978 Jan; 34(1):87-96. PubMed ID: 23995
[TBL] [Abstract][Full Text] [Related]
40. Aging increases expression of LPS-induced autoantibody-secreting B cells.
Meredith PJ; Kristie JA; Walford RL
J Immunol; 1979 Jul; 123(1):87-91. PubMed ID: 312885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
